Two complementary methods for predicting peptides binding major histocompatibility complex molecules

被引:214
作者
Gulukota, K [1 ]
Sidney, J [1 ]
Sette, A [1 ]
DeLisi, C [1 ]
机构
[1] CYTEL CORP,SAN DIEGO,CA 92121
关键词
neural networks; polynomial method; binary decision; independent binding of side-chains;
D O I
10.1006/jmbi.1997.0937
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peptides that bind to major histocompatibility complex products (MHC) are known to exhibit certain sequence motifs which, though common, are neither necessary nor sufficient for binding: MHCs bind certain peptides that do not have the characteristic motifs and only about 30% of the peptides having the required motif, bind. In order to develop and test more accurate methods we measured the binding affinity of 463 nonamer peptides to HLA-A2.1. We describe two methods for predicting whether a given peptide will bind to an MHC and apply them to these peptides. One method is based on simulating a neural network and another, called the polynomial method, is based on statistical parameter estimation assuming independent binding of the side-chains of residues. We compare these methods with each other and with standard motif-based methods. The two methods are complementary, and both are superior to sequence motifs. The neural net is superior to simple motif searches in eliminating false positives. Its behavior can be coarsely tuned to the strength of binding desired and it is extendable in a straightforward fashion to other alleles. The polynomial method, on the other hand, has high sensitivity and is a superior method for eliminating false negatives. We discuss the validity of the independent binding assumption in such predictions. (C) 1997 Academic Press Limited.
引用
收藏
页码:1258 / 1267
页数:10
相关论文
共 27 条
  • [11] SAFETY AND IMMUNOGENICITY IN MAN OF A SYNTHETIC PEPTIDE MALARIA VACCINE AGAINST PLASMODIUM-FALCIPARUM SPOROZOITES
    HERRINGTON, DA
    CLYDE, DF
    LOSONSKY, G
    CORTESIA, M
    MURPHY, JR
    DAVIS, J
    BAQAR, S
    FELIX, AM
    HEIMER, EP
    GILLESSEN, D
    NARDIN, E
    NUSSENZWEIG, RS
    NUSSENZWEIG, V
    HOLLINGDALE, MR
    LEVINE, MM
    [J]. NATURE, 1987, 328 (6127) : 257 - 259
  • [12] CYTOLYTIC LYMPHOCYTE-T RESPONSE TO ISOLATED CLASS-I H-2 PROTEINS AND INFLUENZA PEPTIDES
    KANE, KP
    VITIELLO, A
    SHERMAN, LA
    MESCHER, MF
    [J]. NATURE, 1989, 340 (6229) : 157 - 159
  • [13] KAST WM, 1994, J IMMUNOL, V152, P3904
  • [14] THE ANTIGENIC IDENTITY OF PEPTIDE-MHC COMPLEXES - A COMPARISON OF THE CONFORMATIONS OF 5 VIRAL PEPTIDES PRESENTED BY HLA-A2
    MADDEN, DR
    GARBOCZI, DN
    WILEY, DC
    [J]. CELL, 1993, 75 (04) : 693 - 708
  • [15] MARSHALL KW, 1995, J IMMUNOL, V154, P5927
  • [16] A POTENTIAL PEPTIDE VACCINE AGAINST 2 DIFFERENT STRAINS OF INFLUENZA-VIRUS ISOLATED AT INTERVALS OF ABOUT 10 YEARS
    NARUSE, H
    OGASAWARA, K
    KANEDA, R
    HATAKEYAMA, S
    ITOH, T
    KIDA, H
    MIYAZAKI, T
    GOOD, RA
    ONOE, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (20) : 9588 - 9592
  • [17] IDENTIFICATION OF PEPTIDE SEQUENCES THAT POTENTIALLY TRIGGER HLA-A2.1-RESTRICTED CYTOTOXIC T-LYMPHOCYTES
    NIJMAN, HW
    HOUBIERS, JGA
    VIERBOOM, MPM
    VANDERBURG, SH
    DRIJFHOUT, JW
    DAMARO, J
    KENEMANS, P
    MELIEF, CJM
    KAST, WM
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (06) : 1215 - 1219
  • [18] PARKER KC, 1992, J IMMUNOL, V149, P1896
  • [19] PARKER KC, 1994, J IMMUNOL, V152, P163
  • [20] PROTTI MP, 1993, IMMUNOL TODAY, V14, P363, DOI 10.1016/0167-5699(93)90237-F